Anatomic Pathology Market Worth $44.4 Billion by 2024 - Exclusive Report by MarketsandMarkets(TM)
CHICAGO, Oct. 30, 2019 /PRNewswire/ -- According to the new market research report "Anatomic Pathology Market by Product & Service [instruments (Tissue Processing Systems, Microtomes), Consumables (Antibodies), Histopathology], Application (Disease Diagnosis (Cancer (Gastrointestinal)], End User (Hospital, Lab) - Global Forecast to 2024", published by MarketsandMarkets(TM), the Anatomic Pathology Market is projected to reach a value of USD 44.4 billion by 2024 from USD 33.0 billion in 2019, at a CAGR of 6.1% from 2019 to 2024.
https://mma.prnewswire.com/media/660509/MarketsandMarkets_Logo.jpg
Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=137323145
The high incidence of cancer and other target diseases, availability of reimbursement, and the growing focus on personalized medicine are the major factors driving the growth of the Anatomic Pathology Market.
The services segment accounted for the largest share of the Anatomic Pathology Market, by product & service, in 2018
Based on product & service, the Anatomic Pathology Market is segmented into services, consumables, and instruments. The services segment accounted for the largest share of the Anatomic Pathology Market in 2018. The large share of this segment can be attributed to the availability of reimbursements for diagnostic tests, rapid growth in the geriatric population, and the increasing incidence of cancer and other chronic diseases.
Browse in-depth TOC on "Anatomic Pathology Market"
232 - Tables
35 - Figures
194 - Pages
Hospital laboratories segment to register the highest growth rate during the forecast period
Based on end user, the Anatomic Pathology Market is segmented into hospital laboratories, clinical laboratories, and other end users. In 2018, the hospital laboratories segment accounted for the largest market share and is expected to grow at the highest CAGR during the forecast period. The growth in this market can be attributed to the increasing number of patient visits to hospitals, growing number of in-house diagnostic procedures performed in hospitals, growing awareness regarding early disease diagnosis, and the availability of reimbursements in developed markets for clinical tests performed in hospitals.
Get 10% Customization on this Research Report:
https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=137323145
North America is the largest regional market for anatomic pathology
By region, the Anatomic Pathology Market is segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW). In 2018, North America accounted for the largest market share, followed by Europe. The rising prevalence of chronic diseases, increasing healthcare expenditure, the high-quality infrastructure for hospitals and clinical laboratories, and the presence of major market players in the region are driving the growth of the Anatomic Pathology Market in North America.
The prominent players operating in the Anatomic Pathology Market include F. Hoffmann-La Roche Ltd. (Switzerland), Danaher Corporation (US), Thermo Fisher Scientific (US), Hologic, Inc. (US), Agilent Technologies (US), Becton, Dickinson and Company (US), Sakura Finetek (Japan), Merck KGaA (Germany), Bio SB (US), Diapath S.p.A. (Italy), and BioGenex Laboratories (US).
Browse Adjacent Markets: Medical Devices Market Research Reports & Consulting
Browse Related Reports:
Tissue Diagnostics Market by Product (Consumables, Instruments), Technology (Immunohistochemistry, in Situ Hybridization, Digital Pathology & Workflow), Disease (Breast Cancer, Gastric Cancer, Lymphoma), End User (Hospital, CRO) - Global Forecast to 2022
Slide Stainer Market by Product (Reagent, Equipment (Automated, Manual)), Technology (Hematoxylin & Eosin, Immunohistochemistry, In Situ Hybridization, Microbiology, Special Stains), End User (Hospital, Pharmaceutical, Academic) - Global Forecast to 2023
About MarketsandMarkets(TM)
MarketsandMarkets(TM) provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets(TM) for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets(TM) are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets(TM) now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets(TM) is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Shelly Singh
MarketsandMarkets(TM) INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/anatomic-pathology-market.asp
Visit Our Website: https://www.marketsandmarkets.com
Content Source: https://www.marketsandmarkets.com/PressReleases/anatomic-pathology.asp
View original content:http://www.prnewswire.com/news-releases/anatomic-pathology-market-worth-44-4-billion-by-2024--exclusive-report-by-marketsandmarkets-300947999.html
SOURCE MarketsandMarkets
